F775 in Pennsylvania. Pick another state for the same tag.
Against expectation — 2025
Pennsylvania cites F775 more often than its own record predicts
Versus expected share1.49×
1.49 times the share F775 takes of citations nationally.
Share of Pennsylvania citations0.03%
Of every deficiency written in Pennsylvania in 2025, this is the portion that was F775.
Pennsylvania0.03%
National0.02%
Share of all citations that were F775.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Pennsylvania surveyors wrote
F775 findings written in Pennsylvania, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedDecember 3, 2025
Based on observations, review of facility policies and interviews with staff, it was determined that the facility failed to ensure that drug records are in order and that an account of all controlled drugs is maintained and reconciled for two out of two residents reviewed. (R2, R3)Findings include:Review of facility policy, Storage of Controlled Substances dated 2025, revealed, Medication classified by the Drug Enforcement Administration (DEA) as controlled substances are subject to special handling, storage, disposal, and recordkeeping in the facility in accordance with federal, state and other applicable laws and regulations . …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction